Aspocomp Group Plc
Aspocomp Group Plc, Inside Information, January 15, 2021 at 11:30 a.m.
Aspocomp’s January-December 2020 net sales is estimated to be EUR 25.6 million. Demand in the telecommunications networks and automotive segments in the fourth quarter was lower than expected. Due to the low net sales and the EUR 0.3 million loan provision recorded in the first quarter, Aspocomp’s operating result for January-December 2020 is estimated to
be lower than previously forecast and to be approximately EUR -0.1 million.
In its previous outlook for 2020 (the Interim Report on November 4, 2020) Aspocomp estimated that its net sales and operating result for 2020 will fall significantly short of the 2019 level. In 2019, net sales amounted to EUR 31.2 million and the operating result to EUR 3.4 million.
Aspocomp's Financial Statements release January 1- December 31, 2020 will be released on Wednesday, March 10, 2021 at around 09:00 a.m. (EET). In conjunction with the publication of Aspocomp’s Financial Statements release 2020, Aspocomp will provide an outlook for 2021.
For further information, please contact Mikko Montonen, President and CEO,
tel. +358 40 5011 262, mikko.montonen(at)aspocomp.com.
ASPOCOMP GROUP PLC
Mikko Montonen
President and CEO
Aspocomp – heart of your technology
A printed circuit board (PCB) is used for electrical interconnection and as a component assembly platform in electronic devices. Aspocomp provides PCB technology design, testing and logistics services over the entire lifecycle of a product. The company’s own production and extensive international partner network guarantee cost-effectiveness and reliable deliveries.
Aspocomp’s customers are companies that design and manufacture telecommunication systems and equipment, automotive and industrial electronics, and systems for testing semiconductor components for security technology. The company has customers around the world and most of its net sales are generated by exports.
Aspocomp is headquartered in Espoo and its plant is in Oulu, one of Finland’s major technology hubs.
www.aspocomp.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Evaxion6.12.2025 20:00:00 CET | Press release
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
Genmab A/S6.12.2025 15:30:00 CET | Press release
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Io Therapeutics, Inc.6.12.2025 14:05:00 CET | Press release
Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma
Scatec ASA6.12.2025 08:00:00 CET | Press release
Scatec starts commercial operation at Grootfontein solar power plant in South Africa
Junshi Biosciences6.12.2025 04:11:15 CET | Press release
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
